Clinical Trial Update: Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Triple ACT AL+AQ with ACT AL for falciparum malaria completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria Falciparum

Drugs mentioned

• ACT AL
• Triple ACT AL+AQ

Snippet

Sponsor: University of Oxford | Conditions: Malaria, Falciparum | Phase 3 | Status: COMPLETED | Results posted: 2022-07-15